GETTING MY CONOLIDINE TO WORK

These final results, along with a past report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the notion of targeting ACKR3 as a unique strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar disorders.Conolidine claims to become a groundbreak